Case Information
*1 Case 1:23-cv-00975-RGA-SRF Document 304 Filed 04/29/25 Page 1 of 7 PageID #:
20949 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE UNITED THERAPEUTICS ) CORPORATION, )
) Plaintiff, Civil Action No. 23-975-RGA-SRF ) )
V. ) )
LIQUIDA TECHNOLOGIES, INC., ) )
Defendant. )
MEMORANDUM ORDER At Wilmington this 29th day of April, 2025, the court having considered the parties' letter submissions on plaintiff United Therapeutics Corporation's ("Plaintiff') motion to strike portions of the reply expert reports of Dr. Nicholas Hill and Dr. Stephan Ogenstad, (D.I. 295; D.I. 297), and defendant Liquidia Technologies, Inc.'s ("Defendant") motion to strike portions of the reply expert report of Dr. Ronald A. Thisted, (D.I. 296; D.I. 298), IT IS ORDERED that the pending motion at D.l. 276 is addressed as follows:
1.Plaintifrs motion to strike portions of the reply expert report of Dr. Nicholas Plaintiff moves to strike paragraphs 16 to 17, 77 to 81, 94 Hill is DENIED without prejudice. to 96, 106, 110 to 112, and 148 to 179 of Dr. Hill's reply expert report and to preclude Dr. Hill from testifying at trial regarding the opinions in those paragraphs of the report. Plaintiff has also filed a motion to exclude Dr. Hill's opinion pursuant to Daubert
v. Merrell Dow Pharm., Inc., 509 U.S. 579 (1993). (D.1. 284; D.I. 295 at 1 n.1) For purposes of this discovery dispute, the court focuses only on whether the identified paragraphs in Dr. Hill's reply report untimely offer new opinions on invalidity and inequitable conduct, without reaching the substantive merits of